PLAY PODCASTS
Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

JAMA Editors' Summary · American Medical Association

May 9, 20177m 44s

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

May 09, 2017 edition of the weekly JAMA Editors' Summary